Management and Treatment Principles of Jaundice

1. General Principles

2. Prehepatic (Hemolytic) Jaundice

• Treat the underlying hemolysis: identify and remove offending drugs or toxins; treat infections (e.g., malaria); manage autoimmune hemolytic anemia with corticosteroids.
• Blood transfusion for severe anemia.
• Folic acid supplementation in chronic hemolytic states.
• Hereditary conditions (e.g., spherocytosis) may require splenectomy.
• Gilbert's syndrome and Crigler-Najjar type II (mild): episodes are self-limited; no specific treatment is usually required. Crigler-Najjar type I requires phototherapy and ultimately liver transplantation.

3. Intrahepatic (Hepatocellular) Jaundice

• Viral hepatitis: supportive care; antivirals for Hepatitis B (tenofovir, entecavir) and Hepatitis C (direct-acting antivirals).
• Alcoholic hepatitis: alcohol cessation; corticosteroids (prednisolone) in severe cases; nutritional support.
• Drug-induced liver injury: stop the offending drug; N-acetylcysteine for paracetamol toxicity.
• Autoimmune hepatitis: immunosuppression with prednisolone ± azathioprine.
• Cirrhosis with jaundice: treat complications (ascites, encephalopathy, variceal bleeding); consider liver transplantation. Goldman-Cecil notes that jaundice in cirrhosis reflects liver insufficiency - once decompensation occurs (jaundice, ascites, encephalopathy), median survival drops to ~1.6 years.
• Cholestatic liver disease (PBC, PSC): ursodeoxycholic acid; manage pruritus with cholestyramine, rifampicin, or naltrexone.

4. Posthepatic (Obstructive) Jaundice

Benign Obstruction (Choledocholithiasis)

• ERCP with sphincterotomy and stone extraction is first-line.
• Surgical common bile duct exploration if ERCP fails or is unavailable.
• Cholecystectomy after stone clearance to prevent recurrence.

Malignant Obstruction (Cholangiocarcinoma, Pancreatic Cancer)

• Biliary stenting via ERCP (plastic or self-expanding metal stent) for palliation. A 2024 meta-analysis (PMID 38655140) confirmed that different biliary drainage approaches have varying efficacy/safety profiles in malignant obstruction.
• Percutaneous transhepatic cholangiography (PTC) with drainage when ERCP is not feasible.
• Surgical bypass (hepaticojejunostomy, choledochojejunostomy) for resectable tumors or when endoscopic drainage fails.
• Curative resection (Whipple's procedure for pancreatic head tumors; hepatectomy for cholangiocarcinoma) when technically feasible.

Ascending Cholangitis (Charcot's Triad: jaundice + fever + RUQ pain)

• IV broad-spectrum antibiotics immediately (gram-negative coverage: E. coli, Klebsiella, Enterobacter).
• IV fluid resuscitation.
• Urgent biliary decompression via ERCP with sphincterotomy ± stent, or percutaneous transhepatic drainage.
• Delay risks multiorgan failure from sepsis.

5. Perioperative Management in Jaundiced Patients

• Prophylactic antibiotics: obstructed bile is infected in >95% of cases.
• Renal protection: jaundiced patients have a higher risk of postoperative renal failure (hepatorenal syndrome). Ensure adequate hydration and IV mannitol (10%) intraoperatively. Maintain urine output >40 mL/hr via urethral catheter.
• Coagulation correction: measure prothrombin time; give IM vitamin K preoperatively (bile absence impairs fat-soluble vitamin absorption). Use FFP if urgent correction is needed.
• Wound closure: use mass closure with non-absorbable sutures (impaired wound healing, especially in malignant jaundice).
• Albumin and plasma volume: correct hypoalbuminaemia; avoid excessive saline (jaundiced patients retain salt).

6. Neonatal Jaundice

Unconjugated Hyperbilirubinemia

• Phototherapy: first-line treatment. Blue light (wavelength 460-490 nm) causes a configurational isomerization of bilirubin making it water-soluble and excretable in urine without conjugation. A 2025 meta-analysis (PMID 39586649) confirmed efficacy of blue light therapy.
  • Continue enteral feeding during phototherapy; IV fluids not routinely needed alongside phototherapy.
• Exchange transfusion: for extreme hyperbilirubinemia (emergent); removes both bilirubin and offending antibodies in hemolytic disease.
• Treat underlying cause: hemolytic disease (ABO/Rh incompatibility), G6PD deficiency, sepsis.
• Breast milk jaundice: usually resolves without stopping breastfeeding; phototherapy if needed.
• Breastfeeding (starvation) jaundice: optimize feeds with expressed/donor milk or supplemental formula.

Treatment Thresholds (Tintinalli's Table):

Conjugated Hyperbilirubinemia in Neonates

• Always pathological; requires urgent investigation.
• Biliary atresia: Kasai hepatoportoenterostomy before 8 weeks of age.
• Neonatal hepatitis: supportive; treat identifiable infectious causes.

7. Symptomatic / Supportive Management

• Pruritus relief: cholestyramine (bile acid sequestrant), rifampicin, naltrexone, or antihistamines. Ursodeoxycholic acid in cholestatic liver disease.
• Nutritional support: fat-soluble vitamin supplementation (A, D, E, K) in chronic cholestasis.
• Manage coagulopathy: vitamin K, FFP as needed.
• Treat encephalopathy (if hepatic): lactulose, rifaximin, dietary protein adjustment.
• Avoid hepatotoxic drugs and alcohol.
• Hydration: especially important to protect the kidneys.

Summary Algorithm

Jaundice confirmed (bilirubin > 2.5 mg/dL)
        |
        ├─ Unconjugated (indirect) dominant?
        |       └─ Prehepatic: treat hemolysis, transfuse if needed
        |       └─ Intrahepatic conjugation defect: supportive / specific
        |
        ├─ Mixed (hepatocellular)?
        |       └─ Treat specific liver disease (viral, alcohol, drugs, autoimmune)
        |       └─ Liver transplant if end-stage
        |
        └─ Conjugated (direct) dominant?
                └─ Biliary obstruction confirmed?
                    ├─ Yes (benign): ERCP ± cholecystectomy
                    ├─ Yes (malignant): stenting / surgery / palliation
                    └─ Cholangitis: EMERGENCY - antibiotics + drainage

• Schwartz's Principles of Surgery, 11th Ed. - PMID-referenced classification and posthepatic causes
• Pye's Surgical Handicraft, 22nd Ed. - perioperative management of the jaundiced patient
• Tintinalli's Emergency Medicine - neonatal jaundice, treatment thresholds, phototherapy
• Bailey & Love's Short Practice of Surgery, 28th Ed. - ascending cholangitis management
• Goldman-Cecil Medicine - cirrhosis and jaundice, decompensation prognosis
• Recent evidence: biliary drainage in malignant obstruction meta-analysis (PMID 38655140); blue light phototherapy meta-analysis (PMID 39586649)